Surgical Innovations Group plc Cash Flow Conversion Efficiency

Latest as of December 2025: 0.106x

Surgical Innovations Group plc cash flow conversion efficiency. Based on the latest financial reports, Surgical Innovations Group plc (SUN) has a cash flow conversion efficiency ratio of 0.106x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX808.00K ≈ $98.31 USD) by net assets (GBX7.65 Million ≈ $930.30 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Surgical Innovations Group plc (1991–2025)

Cash flow conversion efficiency of Surgical Innovations Group plc from 1991 to 2025. This chart illustrates how Surgical Innovations Group plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Surgical Innovations Group plc stock price today for real-time trading data and today's change.

Surgical Innovations Group plc Cash Flow Conversion Ratio Explained

Surgical Innovations Group plc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Surgical Innovations Group plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Surgical Innovations Group plc ranked by their cash flow conversion efficiency. Also see SUN market cap for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Electricity Generating Public Company Limited
F:ECGF
0.000x
Sound Energy PLC
LSE:SOU
0.096x
AETHER CATALYST SOLUT.
F:2QZ
0.511x
Verici Dx Plc
LSE:VRCI
-1.091x
Keras Resources PLC
LSE:KRS
-0.132x
Empire Metals Limited
LSE:GEO
-0.066x
CULLINAN METALS CORP.
F:7KO
0.017x
SpaceandPeople Plc
LSE:SAL
0.008x

Annual Cash Flow Conversion Efficiency for Surgical Innovations Group plc (1991–2025)

The table below shows the annual cash flow conversion efficiency of Surgical Innovations Group plc from 1991 to 2025. Review Surgical Innovations Group plc (SUN) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 GBX7.65 Million
≈ $930.30
GBX569.00K
≈ $69.23
0.074x +958.92%
2024-12-31 GBX8.54 Million
≈ $1.04K
GBX-74.00K
≈ $-9.00
-0.009x -122.71%
2023-12-31 GBX10.48 Million
≈ $1.28K
GBX400.00K
≈ $48.67
0.038x -13.94%
2022-12-31 GBX10.96 Million
≈ $1.33K
GBX486.00K
≈ $59.13
0.044x +209.18%
2021-12-31 GBX10.66 Million
≈ $1.30K
GBX-433.00K
≈ $-52.68
-0.041x -143.21%
2020-12-31 GBX11.09 Million
≈ $1.35K
GBX1.04 Million
≈ $126.78
0.094x +92.85%
2019-12-31 GBX12.19 Million
≈ $1.48K
GBX594.00K
≈ $72.27
0.049x -57.41%
2018-12-31 GBX14.42 Million
≈ $1.75K
GBX1.65 Million
≈ $200.76
0.114x -2.42%
2017-12-31 GBX13.72 Million
≈ $1.67K
GBX1.61 Million
≈ $195.65
0.117x -75.94%
2016-12-31 GBX5.84 Million
≈ $710.32
GBX2.85 Million
≈ $346.15
0.487x +27.17%
2015-12-31 GBX3.93 Million
≈ $478.17
GBX1.51 Million
≈ $183.24
0.383x +583.47%
2014-12-31 GBX6.12 Million
≈ $744.51
GBX-485.00K
≈ $-59.01
-0.079x -190.73%
2013-12-31 GBX14.52 Million
≈ $1.77K
GBX1.27 Million
≈ $154.28
0.087x +93.60%
2012-12-31 GBX13.56 Million
≈ $1.65K
GBX612.00K
≈ $74.46
0.045x -67.93%
2011-12-31 GBX12.62 Million
≈ $1.54K
GBX1.77 Million
≈ $215.97
0.141x -32.35%
2010-12-31 GBX10.59 Million
≈ $1.29K
GBX2.20 Million
≈ $267.92
0.208x +24.87%
2009-12-31 GBX8.64 Million
≈ $1.05K
GBX1.44 Million
≈ $175.08
0.167x +19029.56%
2008-12-31 GBX8.04 Million
≈ $978.24
GBX7.00K
≈ $0.85
0.001x +101.51%
2007-12-31 GBX7.41 Million
≈ $901.58
GBX-428.00K
≈ $-52.08
-0.058x -125.87%
2006-12-31 GBX2.80 Million
≈ $340.56
GBX625.00K
≈ $76.04
0.223x +103.29%
2005-12-31 GBX2.09 Million
≈ $254.78
GBX230.00K
≈ $27.98
0.110x +126.54%
2004-12-31 GBX1.65 Million
≈ $200.76
GBX80.00K
≈ $9.73
0.048x -73.48%
2003-12-31 GBX1.40 Million
≈ $169.73
GBX255.00K
≈ $31.03
0.183x +254.14%
2002-12-31 GBX1.25 Million
≈ $151.85
GBX-148.00K
≈ $-18.01
-0.119x -19.74%
2001-12-31 GBX1.14 Million
≈ $138.83
GBX-113.00K
≈ $-13.75
-0.099x +66.15%
2000-12-31 GBX1.06 Million
≈ $128.48
GBX-309.00K
≈ $-37.60
-0.293x -150.68%
1999-12-31 GBX-762.00K
≈ $-92.71
GBX-440.00K
≈ $-53.54
0.577x -96.25%
1998-12-31 GBX-68.00K
≈ $-8.27
GBX-1.05 Million
≈ $-127.51
15.412x +401.34%
1996-08-31 GBX201.00K
≈ $24.46
GBX-1.03 Million
≈ $-125.08
-5.114x -211.48%
1995-08-31 GBX1.20 Million
≈ $146.13
GBX-1.97 Million
≈ $-239.94
-1.642x -94.91%
1994-08-31 GBX2.75 Million
≈ $335.08
GBX-2.32 Million
≈ $-282.28
-0.842x -153.87%
1993-08-31 GBX5.32 Million
≈ $647.17
GBX-1.76 Million
≈ $-214.75
-0.332x +67.60%
1992-08-31 GBX1.37 Million
≈ $166.57
GBX-1.40 Million
≈ $-170.58
-1.024x +1.91%
1991-08-31 GBX1.68 Million
≈ $204.65
GBX-1.76 Million
≈ $-213.65
-1.044x --

About Surgical Innovations Group plc

LSE:SUN UK Medical Devices
Market Cap
$36.89K
GBX303.17 Million GBX
Market Cap Rank
#31721 Global
#1225 in UK
Share Price
GBX0.33
Change (1 day)
+0.00%
52-Week Range
GBX0.33 - GBX0.58
All Time High
GBX4.63
About

Surgical Innovations Group plc, together with its subsidiaries, engages in the design, manufacture, and export of medical products for use in laparoscopic and robotic minimally invasive surgery in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally. It operates through SI Brand, Original Equipment Manufacturer (OEM), and Distribution segments. The company provides… Read more